Naoto Hirano

A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.

Ryuichi Sakai, Akihiro Iwamatsu, Naoto Hirano et al. · The EMBO Journal · 1994 · 653 citations · Full text

A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects

Yuki Kagoya, Shinya Tanaka, Tingxi Guo et al. · Nature Medicine · 2018 · 560 citations

Immunology, Tumor Immunity, Immunoediting +6

Transplantation of Anergic Histoincompatible Bone Marrow Allografts

Eva C. Guinan, Vassiliki A. Boussiotis, Donna Neuberg et al. · New England Journal of Medicine · 1999 · 435 citations

Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells

Dimitrios Tzachanis, Gordon J. Freeman, Naoto Hirano et al. · Nature Immunology · 2001 · 274 citations

Signal Transduction, Negative Regulator, T-regulatory Cell +9

BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models

Yuki Kagoya, Munehide Nakatsugawa, Yūki Yamashita et al. · Journal of Clinical Investigation · 2016 · 210 citations · Full text